Upgrade to SI Premium - Free Trial

AIDX (AIDX)

0.48 -0.04 (7.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research September 15, 2026 6:02 AM - StreetInsider Form 8-K 20/20 Biolabs, Inc. For: Sep 03 September 10, 2026 4:11 PM - SEC Filing Healwell's Darwen AI to match clinical trials to 100K+ consented patients September 8, 2026 6:34 AM - StreetInsider WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents September 8, 2026 6:32 AM - StreetInsider HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients September 8, 2026 6:32 AM - StreetInsider HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange September 1, 2026 6:02 AM - StreetInsider 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity August 28, 2026 6:26 PM - Globe NewsWire 20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity August 26, 2026 8:31 AM - StreetInsider Form DEFA14A 20/20 Biolabs, Inc. August 19, 2026 4:51 PM - SEC Filing Form 8-K 20/20 Biolabs, Inc. For: Aug 18 August 19, 2026 9:19 AM - SEC Filing Form 424B3 20/20 Biolabs, Inc. August 17, 2026 4:15 PM - SEC Filing Form 424B3 20/20 Biolabs, Inc. August 17, 2026 4:10 PM - SEC Filing Form 8-K 20/20 Biolabs, Inc. For: Aug 17 August 17, 2026 4:06 PM - SEC Filing 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level August 17, 2026 8:31 AM - StreetInsider Form 10-Q 20/20 Biolabs, Inc. For: Jun 30 August 14, 2026 4:13 PM - SEC Filing Form 8-K 20/20 Biolabs, Inc. For: Aug 05 August 5, 2026 12:01 PM - SEC Filing 20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour July 30, 2026 8:31 AM - StreetInsider 20/20 BioLabs meets with East Asia partners to explore expansion July 27, 2026 4:30 PM - StreetInsider 20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy July 27, 2026 4:30 PM - StreetInsider 20/20 BioLabs reaches standstill deal on Series E preferred stock July 23, 2026 8:32 AM - StreetInsider 20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock July 23, 2026 8:31 AM - StreetInsider Form 8-K 20/20 Biolabs, Inc. For: Jul 16 July 22, 2026 4:45 PM - SEC Filing 20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy July 9, 2026 4:01 PM - StreetInsider 20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth July 9, 2026 4:01 PM - StreetInsider Form 8-K 20/20 Biolabs, Inc. For: Jul 01 July 1, 2026 3:29 PM - SEC Filing Form DEFA14A 20/20 Biolabs, Inc. June 23, 2026 5:03 PM - SEC Filing Form DEF 14A 20/20 Biolabs, Inc. For: Aug 18 June 23, 2026 5:02 PM - SEC Filing 20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month June 22, 2026 4:45 PM - StreetInsider Full Article List